The Maryland Technology Development Corp. has awarded a $750,000 grant to Longeveron LLC, a Miami-based biopharmaceutical company, to study whether stem cells can make a better flu vaccine for seniors with a researcher from Johns Hopkins University School of Medicine.
{iframe}http://www.baltimoresun.com/business/bs-bz-stem-cell-studies-get-grants-20180522-story.html{/iframe}